Table 1.
Characteristics of the 219 patients with a venous access port during the study perioda
| Characteristic | No. (%) |
P value | ||
|---|---|---|---|---|
| Total (n = 219) | Non-VAP-RBSI (n = 204) | VAP-RBSI (n = 15) | ||
| Age (yr), mean (SD) | 54.5 (17.80) | 54.26 (18.10) | 54.08 (18.64) | 0.970 |
| Male sex | 88 (40.2) | 77 (37.7) | 11 (73.3) | 0.015 |
| Underlying disease | ||||
| Colorectal cancer | 50 (22.8) | 48 (23.5) | 2 (13.3) | 0.556 |
| Breast cancer | 48 (21.9) | 47 (23.0) | 1 (11.1) | 0.248 |
| Lymphoma | 34 (15.5) | 34 (16.7) | 0 (0.0) | 0.177 |
| ENT cancer | 14 (6.4) | 10 (4.9) | 4 (26.7) | 0.006 |
| Leukemia | 13 (5.9) | 11 (5.4) | 2 (13.3) | 0.490 |
| Cervical cancer | 12 (5.5) | 12 (5.9) | 0 (0.0) | 0.705 |
| Digestive tract cancer | 8 (3.7) | 5 (2.5) | 3 (20.0) | 0.005 |
| Ovarian cancer | 3 (1.4) | 1 (0.5) | 2 (13.3) | 0.003 |
| Fibroma | 1 (0.5) | 0 (0.0) | 1 (6.7) | 0.087 |
| Other | 36 (16.4) | 36 (17.6) | 0 (0.0) | 0.156 |
| Charlson comorbidity index, median (IQR)b | 5 (2.00–7.00) | |||
| McCabe and Jackson score, median (IQR)b | 3 (2–3) | |||
| Cumulative catheter days | 136,356 | 125,198 | 11,158 | |
| Catheter days, median (IQR) | 435 (212–902) | 427 (214.50–896.50) | 613 (172.00–1,020.00) | 0.001 |
| No. of times of catheter use, median (IQR) | 20 (2–50) | 20 (3.00–48.00) | 25 (0.00–52.00) | 0.054 |
| Site of catheter insertion | ||||
| Jugular vein | 198 (90.4) | 187 (91.7) | 11 (73.3) | 0.061 |
| Subclavian vein | 21 (9.6) | 17 (8.3) | 4 (26.7) | 0.061 |
| Time of blood draw for cultureb | ||||
| Before catheter withdrawal | 14 (93.3) | |||
| At the time of catheter withdrawal | 0 (0.0) | |||
| After catheter withdrawal | 1 (6.7) | |||
| Reason for catheter withdrawal | ||||
| End of use | 135 (61.6) | 135 (66.2) | 0 (0.0) | <0.001 |
| Suspicion of bloodstream infection | 41 (18.7) | 30 (14.7) | 11 (73.3) | <0.001 |
| Suspicion of local infection | 21 (9.6) | 17 (8.3) | 4 (26.7) | 0.061 |
| Obstruction-malfunction | 15 (6.8) | 15 (7.4) | 0 (0.0) | 0.577 |
| Thrombosis | 4 (1.8) | 4 (2.0) | 0 (0.0) | 0.652 |
| Other | 3 (1.4) | 3 (1.5) | 0 (0.0) | 0.498 |
| Appearance of insertion site | ||||
| Intact | 190 (86.8) | 186 (91.2) | 4 (26.7) | <0.001 |
| Swollen | 16 (7.3) | 13 (6.4) | 3 (20.0) | 0.149 |
| Ulcerated | 10 (4.6) | 4 (2.0) | 6 (40.0) | <0.001 |
| Suppurative | 3 (1.4) | 1 (0.5) | 2 (13.3) | 0.003 |
| DDDs, median (IQR)b | 24 (17.80–70.00) | |||
| Total days of therapy, median (IQR)b | 19 (14.00–28.00) | |||
| Antibiotic use before catheter withdrawalb | 11 (73.3) | |||
a
Values are numbers with percentages in parentheses unless otherwise indicated. ENT, ear, nose, and throat; IQR, interquartile range; DDDs, defined daily doses. Boldface indicates statistical significance (P < 0.05).
b
Recorded only for patients with VAP-RBSI.